Peter Attia· MD
the the the key factor for the women's health initiatives is the women didn't start doing it until 10 years after menopause on average and so there have been shorter term for women that start replacement therapy earlier and then stop it that there may be this window in which it's benefit but of course it depends on your family history yeah but my point is there was no there was no increase in mortality i think if you really scrutinize the whi data correctly even the the the most headline grabbing um finding which was that the women in the progesterone and conjugated equine estrogen group had a greater 25 percent greater risk of breast cancer i mean i think we now understand that that was a very misleading finding